Literature DB >> 8132868

Clusterin (SGP-2): a multifunctional glycoprotein with regional expression in astrocytes and neurons of the adult rat brain.

G M Pasinetti1, S A Johnson, T Oda, I Rozovsky, C E Finch.   

Abstract

Clusterin (SGP-2) is a newly described glycoprotein associated with several putative functions including responses to brain injury. This study reports the regional and cell type expression of clusterin mRNA and its encoded glycoprotein in the rat brain; a limited comparison was also done with the human brain. Using in situ hybridization combined with immunocytochemistry, we found that astrocytes and neurons may express clusterin mRNA in the normal adult brain. While astrocytes throughout the brain contained clusterin mRNA, there was regional selectivity for neuronal clusterin expression. In the striatum, clusterin mRNA was not detected in neurons. Only a subset of substantia nigra dopaminergic neurons or locus ceruleus noradrenergic neurons (tyrosine hydroxylase immunopositive) contained clusterin mRNA. However, neuronal clusterin mRNA was prevalent in pontine nuclei and in the red nucleus of the midbrain tegmentum. Similarly, clusterin mRNA was prevalent in both rat and human hippocampal neuron-specific enolase immunopositive pyramidal neurons, although rat CA1 neurons had less mRNA than CA2-CA3 neurons. Monotypic primary cell cultures from the neonatal rat showed clusterin mRNA in both neurons and astrocytes, but not in microglia. By immunocytochemistry, no clusterin immunopositive glia were observed in any region of the rat brain, confirming previous studies. However, clusterin immunopositive cells (putative neurons) were observed in the Purkinje cell layer of the cerebellum, medial and interposed cerebellar nuclei, trigeminal motor nucleus, and red nucleus. Finally, in vitro studies suggest that astrocytes, but not neurons, secrete clusterin, which is pertinent to clusterin immunodeposits found after experimental lesioning.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8132868     DOI: 10.1002/cne.903390307

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  22 in total

1.  Nerve growth factor and epidermal growth factor stimulate clusterin gene expression in PC12 cells.

Authors:  C Gutacker; G Klock; P Diel; C Koch-Brandt
Journal:  Biochem J       Date:  1999-05-01       Impact factor: 3.857

2.  Loss of clusterin shifts amyloid deposition to the cerebrovasculature via disruption of perivascular drainage pathways.

Authors:  Aleksandra M Wojtas; Silvia S Kang; Benjamin M Olley; Maureen Gatherer; Mitsuru Shinohara; Patricia A Lozano; Chia-Chen Liu; Aishe Kurti; Kelsey E Baker; Dennis W Dickson; Mei Yue; Leonard Petrucelli; Guojun Bu; Roxana O Carare; John D Fryer
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-12       Impact factor: 11.205

3.  Apolipoproteins in the brain: implications for neurological and psychiatric disorders.

Authors:  David A Elliott; Cyndi Shannon Weickert; Brett Garner
Journal:  Clin Lipidol       Date:  2010-08-01

4.  Clusterin secreted by astrocytes enhances neuronal differentiation from human neural precursor cells.

Authors:  O Cordero-Llana; S A Scott; S L Maslen; J M Anderson; J Boyle; R-R Chowhdury; P Tyers; R A Barker; C M Kelly; A E Rosser; E Stephens; S Chandran; M A Caldwell
Journal:  Cell Death Differ       Date:  2011-01-07       Impact factor: 15.828

5.  Potentiation of excitotoxicity in transgenic mice overexpressing neuronal cyclooxygenase-2.

Authors:  K A Kelley; L Ho; D Winger; J Freire-Moar; C B Borelli; P S Aisen; G M Pasinetti
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

6.  Quantitative temporal proteomic analysis of human embryonic stem cell differentiation into oligodendrocyte progenitor cells.

Authors:  Raghothama Chaerkady; Brian Letzen; Santosh Renuse; Nandini A Sahasrabuddhe; Praveen Kumar; Angelo H All; Nitish V Thakor; Bernard Delanghe; John D Gearhart; Akhilesh Pandey; Candace L Kerr
Journal:  Proteomics       Date:  2011-09-02       Impact factor: 3.984

Review 7.  Cholesterol 24-Hydroxylation by CYP46A1: Benefits of Modulation for Brain Diseases.

Authors:  Alexey M Petrov; Irina A Pikuleva
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

8.  Expression of the protein chaperone, clusterin, in spinal cord cells constitutively and following cellular stress, and upregulation by treatment with Hsp90 inhibitor.

Authors:  Samantha Zinkie; Benoit J Gentil; Sandra Minotti; Heather D Durham
Journal:  Cell Stress Chaperones       Date:  2013-04-19       Impact factor: 3.667

9.  Implication of complement system and its regulators in Alzheimer's disease.

Authors:  Martin V Kolev; Marieta M Ruseva; Claire L Harris; B Paul Morgan; Rossen M Donev
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

10.  Retrospective Case-Control Study of Apolipoprotein J/Clusterin Protein Expression in Early Liveborn Neonatal Deaths with and without Pontosubicular Necrosis.

Authors:  Kathreena M Kurian; Declan McGuone
Journal:  Patholog Res Int       Date:  2012-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.